Life ScienceCompany
Intra-Cellular Therapies Ownership
Who owns Intra-Cellular Therapies?
Intra-Cellular Therapies is owned by Johnson & Johnson. It was acquired on January 13, 2025.
Intra-Cellular Therapies Business Overview
Where is Intra-Cellular Therapies headquartered?
Intra-Cellular Therapies is headquartered in Bedminster, New Jersey.
What is Intra-Cellular Therapies’ revenue?
Intra-Cellular Therapies disclosed revenue of 462M USD for 2023 and 249M USD for 2022.
How many employees does Intra-Cellular Therapies have?
Intra-Cellular Therapies has 610 employees.
What sector is Intra-Cellular Therapies in?
Intra-Cellular Therapies is a life science company.
When was Intra-Cellular Therapies founded?
Intra-Cellular Therapies was founded in 2002.
Life Science M&A Summary in 2025
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.
Join Mergr to view all 55 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 52 by strategics.